Cambridge Heatlthtech Institute's 2nd Annual

Engineering Antibody-Drug Conjugates

Designing the Magic Bullet

12 November 2025 ALL TIMES WET (GMT/UTC)


Cambridge Healthtech Institute’s 2nd Annual Engineering Antibody-Drug Conjugates conference showcases state-of-the-art innovations in bispecific ADC platforms, dual payloads, novel mechanisms of action, as well as next-generation ADC formats including antibody-olignucleotide conjugates and degrader-antibody conjugates. Join leading researchers and industry innovators in driving these targeted therapies toward clinical success.

Recommended Short Course*
Monday, 4 November, 14:00 – 17:00
SC5: Novel Payloads and Conjugation Strategies – Building on Lessons Learned to Inform Next-Generation ADC Design
*Separate registration required. See short courses page for details. All short courses take place in-person only.





For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com